Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NIH offers new technology for licensing

March 2, 1998

First potent and selective CB2 receptor antagonist developed at Sanofi

Feb. 24, 1998

Pneumovax does not prevent pneumonia in middle-aged and elderly immunocompetent patients

Feb. 19, 1998

Cytokine-inducing profile of imiquimod and two analogues characterized in monkeys

Feb. 19, 1998

Zenapax uveitis and transplant trial data reported

Feb. 19, 1998

FDA issues positive action letter for SangStat's ciclosporin; European filing announced

Feb. 19, 1998

First launch for Zenapax

Feb. 17, 1998

Immunosuppressive profile of activity of PS-64 extract

Feb. 17, 1998

Novel immunosuppressive extract magnifies the efficacy of ciclosporin in vitro

Feb. 17, 1998

New formulation of FK-506 demonstrates superior efficacy

Feb. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....